Last reviewed · How we verify

Ceredase — Competitive Intelligence Brief

Ceredase (ALGLUCERASE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hydrolytic Lysosomal Glucocerebroside-specific Enzyme. Area: Neuroscience.

marketed Hydrolytic Lysosomal Glucocerebroside-specific Enzyme Neuroscience Enzyme Live · refreshed every 30 min

Target snapshot

Ceredase (ALGLUCERASE) — Sanofi.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ceredase TARGET ALGLUCERASE Sanofi marketed Hydrolytic Lysosomal Glucocerebroside-specific Enzyme 1991-01-01
TALIGLUCERASE ALFA TALIGLUCERASE ALFA marketed Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] glucocerebrosidase 2012-01-01
Vpriv VELAGLUCERASE ALFA Shire Human Genetic marketed Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 2010-01-01
Cerezyme IMIGLUCERASE Sanofi marketed Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1994-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hydrolytic Lysosomal Glucocerebroside-specific Enzyme class)

  1. Sanofi · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ceredase — Competitive Intelligence Brief. https://druglandscape.com/ci/alglucerase. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: